biotin sp affinipure rabbit anti human igg fcγ fragment specific Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • biotin sp affinipure rabbit anti human igg fcγ fragment specific  (Jackson Immuno)
    92
    Jackson Immuno biotin sp affinipure rabbit anti human igg fcγ fragment specific
    Titres of Anti-NSP2 antibodies in cord blood collected at birth and in serum following dosing with RV3-BB or Placebo according to the schedule described in the Materials and methods. Serum <t>IgA</t> (A) and serum <t>IgG</t> (B) in Neonatal and Infant schedules by dose and compared to Placebo. Data points represent individual serum samples, horizontal lines represent the geometric mean titre (GMT). Data is transformed onto a natural log scale. * Significant difference between geometric mean.
    Biotin Sp Affinipure Rabbit Anti Human Igg Fcγ Fragment Specific, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 92/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin sp affinipure rabbit anti human igg fcγ fragment specific/product/Jackson Immuno
    Average 92 stars, based on 8 article reviews
    Price from $9.99 to $1999.99
    biotin sp affinipure rabbit anti human igg fcγ fragment specific - by Bioz Stars, 2021-01
    92/100 stars
    		  Buy from Supplier
    Biotin SP long spacer AffiniPure F ab ₂ Fragment Rabbit Anti Human IgG Fcγ fragment specific  (Jackson Immuno)
    N/A
    F ab 2 fragment antibodies are generated by pepsin digestion of whole IgG antibodies to remove most of the Fc region while leaving some of the hinge region F ab
    		   Buy from Supplier

    Image Search Results


    Titres of Anti-NSP2 antibodies in cord blood collected at birth and in serum following dosing with RV3-BB or Placebo according to the schedule described in the Materials and methods. Serum IgA (A) and serum IgG (B) in Neonatal and Infant schedules by dose and compared to Placebo. Data points represent individual serum samples, horizontal lines represent the geometric mean titre (GMT). Data is transformed onto a natural log scale. * Significant difference between geometric mean.

    Journal: Human Vaccines & Immunotherapeutics

    Article Title: Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine

    doi: 10.1080/21645515.2018.1467202

    Figure Lengend Snippet: Titres of Anti-NSP2 antibodies in cord blood collected at birth and in serum following dosing with RV3-BB or Placebo according to the schedule described in the Materials and methods. Serum IgA (A) and serum IgG (B) in Neonatal and Infant schedules by dose and compared to Placebo. Data points represent individual serum samples, horizontal lines represent the geometric mean titre (GMT). Data is transformed onto a natural log scale. * Significant difference between geometric mean.

    Article Snippet: Serum samples at a single dilution (1:20 for IgA and 1:100 for IgG) were added and incubated at 37°C for 1.5 h. The bound antibodies were bound with biotinylated anti-human IgA or IgG (Jackson ImmunoResearch Laboratories Cat #309-065-011 and 309-065-008) (diluted 1:8,000 for IgA and 1:32,000 for IgG) incubated at 37°C for 1.5 h. The antigen–antibody complexes were detected with streptavidin-horseradish peroxidase (diluted 1:200,000) (Invitrogen, Cat# SNN1004).

    Techniques: Transformation Assay

    Titres of Anti-RV3-BB antibodies in cord blood collected at birth and in serum following dosing with RV3-BB or Placebo according to the schedule described in the Materials and methods. Serum IgA (A) and serum IgG (B) in Neonatal and Infant schedules by dose and compared to Placebo. Data points represent individual serum samples, horizontal lines represent the geometric mean titre (GMT). Data is transformed onto a natural log scale. * Significant difference between geometric mean.

    Journal: Human Vaccines & Immunotherapeutics

    Article Title: Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine

    doi: 10.1080/21645515.2018.1467202

    Figure Lengend Snippet: Titres of Anti-RV3-BB antibodies in cord blood collected at birth and in serum following dosing with RV3-BB or Placebo according to the schedule described in the Materials and methods. Serum IgA (A) and serum IgG (B) in Neonatal and Infant schedules by dose and compared to Placebo. Data points represent individual serum samples, horizontal lines represent the geometric mean titre (GMT). Data is transformed onto a natural log scale. * Significant difference between geometric mean.

    Article Snippet: Serum samples at a single dilution (1:20 for IgA and 1:100 for IgG) were added and incubated at 37°C for 1.5 h. The bound antibodies were bound with biotinylated anti-human IgA or IgG (Jackson ImmunoResearch Laboratories Cat #309-065-011 and 309-065-008) (diluted 1:8,000 for IgA and 1:32,000 for IgG) incubated at 37°C for 1.5 h. The antigen–antibody complexes were detected with streptavidin-horseradish peroxidase (diluted 1:200,000) (Invitrogen, Cat# SNN1004).

    Techniques: Transformation Assay